Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion type Assertion NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_head.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion description "[To explore their impact on this favourable-risk disease, we determined GATA2 status in 153 sporadic AML patients and three members of a germ-line CEBPA-mutant family at AML presentation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_provenance.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion evidence source_evidence_literature NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_provenance.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion SIO_000772 23560626 NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_provenance.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion wasDerivedFrom befree-2016 NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_provenance.
- NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_assertion wasGeneratedBy ECO_0000203 NP1066850.RAtSo2QAF8LNVkxSsFB12bbDEIx8sODGsiyQg2vpa5rqI130_provenance.